Certain bacteria, including Akkermansia muciniphila, support GLP-1 secretion by improving gut barrier function, reducing inflammation, and promoting the production of short-chain fatty acids
Consistent with findings from the OASIS 1 trial [23], only 5% of patients discontinued treatment due to gastrointestinal intolerance
The company has launched an upgraded version of its GLP-1 Premium formula, designed to support appetite control, digestive function, and long-term metabolic balance in a more comprehensive way
Some focus just on weight loss, while others include diabetes management or advice specific to people on GLP-1 drugs, like Ozempic
Doctors diagnose gastroparesis by looking at symptoms and measuring how slowly the stomach empties